Candriam SCA’s Veracyte VCYT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q4
Sell
-231,676
Closed -$7.89M 711
2024
Q3
$7.89M Sell
231,676
-439,261
-65% -$12.4M 0.05% 297
2024
Q2
$14.5M Hold
670,937
0.09% 211
2024
Q1
$14.9M Buy
670,937
+60,005
+10% +$1.46M 0.1% 206
2023
Q4
$16.8M Buy
+610,932
New +$14.7M 0.12% 182
2023
Q3
Sell
-600,926
Closed -$15.3M 691
2023
Q2
$15.3M Sell
600,926
-21,220
-3% -$514K 0.11% 194
2023
Q1
$12.8M Buy
622,146
+20,000
+3% +$483K 0.09% 222
2022
Q4
$14.3M Buy
602,146
+223,483
+59% +$5.19M 0.1% 212
2022
Q3
$6.29M Hold
378,663
0.04% 345
2022
Q2
$7.54M Hold
378,663
0.06% 269
2022
Q1
$10.4M Buy
+378,663
New +$10.8M 0.07% 250
2020
Q4
Sell
-202,595
Closed -$6.58M 850
2020
Q3
$6.58M Sell
202,595
-6,420
-3% -$204K 0.06% 310
2020
Q2
$5.41M Buy
209,015
+45,591
+28% +$1.14M 0.06% 318
2020
Q1
$4.46M Buy
163,424
+33
+0% +$831 0.05% 380
2019
Q4
$4.56M Buy
163,391
+72,329
+79% +$1.87M 0.05% 388
2019
Q3
$2.19M Buy
91,062
+9,500
+12% +$253K 0.03% 469
2019
Q2
$2.31M Buy
81,562
+19,600
+32% +$490K 0.03% 484
2019
Q1
$1.55M Buy
+61,962
New +$1.18M 0.02% 551

Other funds holding VCYT

Candriam SCA's VCYT Position: Q4 2024 in Review

Candriam SCA sold out of Veracyte (VCYT) in Q4 2024, closing a stake of 231,676 shares — an estimated $7.89M sold.

Candriam SCA first reported a position in VCYT in Q1 2019 and held it in 17 quarters. The position peaked at $16.8M in Q4 2023. 318 funds tracked by Wall St. Rank hold VCYT as of Q4 2024.

  • Candriam SCA reported no remaining Veracyte position as of Q4 2024 after selling out during the quarter.
  • Candriam SCA sold 231,676 Veracyte shares in Q4 2024, an estimated $7.89M.
  • Candriam SCA first reported a position in Veracyte in Q1 2019 and held it in 17 quarters.
  • Candriam SCA's Veracyte position peaked at $16.8M in Q4 2023.
  • 318 funds tracked by Wall St. Rank held Veracyte as of Q4 2024.

Based on Candriam SCA's 13F filing for Q4 2024, filed 7 Feb 2025.